Literature DB >> 10075417

Antigenic characterization and cytolocalization of P35, the major Mycoplasma penetrans antigen.

Olivier Neyrolles1, Jean-Pierre Eliane1, Stéphane Ferris1, Regina Ayr Florio da Cunha1, Marie-Christine Prevost1, Elmostafa Bahraoui2, Alain Blanchard1.   

Abstract

Mycoplasma penetrans is a mycoplasma with unique morphology, recently identified in urine samples collected from HIV-infected patients. This mycoplasma has been found to be statistically associated with HIV infection, and to be cytopathic in vitro. The dominant antigen recognized during natural and experimental infections is an abundant lipoprotein, P35, which, upon extraction, segregates in the Triton X-114 detergent phase. It is used as the basis of M. penetrans-specific serological assays. Although mycoplasma lipoproteins, including M. penetrans P35, are the main antigens recognized by the host humoral immune response, very little is known about the nature of the epitopes involved. Immunoelectron microscopy revealed that all P35 is exposed at the cell surface and is distributed all over the membrane. P35 linear B-epitopes were mapped by an ELISA approach based on a set of overlapping peptides covering the entire mature polypeptide. The immunoreactivity of the peptides was first tested with sera from immunized animals. The dominant B-epitopes were found at the C- and N-terminal regions, in partial agreement with algorithmic predictions. Patient sera were evaluated with the same assay. Only some reacted with linear epitopes whereas others did not, indicating the importance of P35 nonsequential epitopes. Statistical analysis of the results allowed the definition of a set of peptides which were clearly immunodominant. Finally, the P35-encoding gene was modified by in vitro mutagenesis to allow the production and purification of a recombinant protein (rP35delta0) in Escherichia coil. The antigenicity of rP35delta0 was tested by Western blotting and compared to that of another recombinant product, rP35delta3, a truncated P35 polypeptide. Although rP35delta0 reacted with the M. penetrans-seropositive patient sera tested, rP35delta3 was only immunoreactive with one of six sera. This result confirmed that P35-nonsequential epitopes dominate during M. penetrans infection. Our results have important implications for the understanding of lipoprotein antigenicity during mycoplasma infections. In addition, the P35-derived immunodominant synthetic peptides defined in this study, as well as the purified rP35delta0, provide the antigenic material for the necessary improvement of M. penetrans serological assays.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10075417     DOI: 10.1099/13500872-145-2-343

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  10 in total

1.  The complete genomic sequence of Mycoplasma penetrans, an intracellular bacterial pathogen in humans.

Authors:  Yuko Sasaki; Jun Ishikawa; Atsushi Yamashita; Kenshiro Oshima; Tsuyoshi Kenri; Keiko Furuya; Chie Yoshino; Atsuko Horino; Tadayoshi Shiba; Tsuguo Sasaki; Masahira Hattori
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

2.  Multiple promoter inversions generate surface antigenic variation in Mycoplasma penetrans.

Authors:  Atsuko Horino; Yuko Sasaki; Tsuguo Sasaki; Tsuyoshi Kenri
Journal:  J Bacteriol       Date:  2003-01       Impact factor: 3.490

3.  Development a rapid and accurate multiplex real time PCR method for the detection Chlamydia trachomatis and Mycoplasma hominis.

Authors:  Roya Safarkar; Jalil Fallah Mehrabadi; Zahra Noormohammadi; Reza Mirnejad
Journal:  J Clin Lab Anal       Date:  2017-02-26       Impact factor: 2.352

4.  Phase variations of the Mycoplasma penetrans main surface lipoprotein increase antigenic diversity.

Authors:  O Neyrolles; I Chambaud; S Ferris; M C Prevost; T Sasaki; L Montagnier; A Blanchard
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

5.  The Variable Internal Structure of the Mycoplasma penetrans Attachment Organelle Revealed by Biochemical and Microscopic Analyses: Implications for Attachment Organelle Mechanism and Evolution.

Authors:  Steven L Distelhorst; Dominika A Jurkovic; Jian Shi; Grant J Jensen; Mitchell F Balish
Journal:  J Bacteriol       Date:  2017-05-25       Impact factor: 3.490

6.  Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to membrane-active peptides and enrofloxacin in human tissue cell cultures.

Authors:  Ran Nir-Paz; Marie-Christine Prévost; Pierre Nicolas; Alain Blanchard; Henri Wróblewski
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

7.  Phase variation among major surface antigens of Mycoplasma penetrans.

Authors:  K Röske; A Blanchard; I Chambaud; C Citti; J H Helbig; M C Prevost; R Rosengarten; E Jacobs
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

8.  Binding of IgA by Mycoplasma penetrans.

Authors:  Awni Moussa; Ran Nir-Paz; Shlomo Rottem
Journal:  Curr Microbiol       Date:  2009-02-03       Impact factor: 2.188

Review 9.  Common strategies for antigenic variation by bacterial, fungal and protozoan pathogens.

Authors:  Kirk W Deitsch; Sheila A Lukehart; James R Stringer
Journal:  Nat Rev Microbiol       Date:  2009-06-08       Impact factor: 60.633

10.  Multiple genome comparison within a bacterial species reveals a unit of evolution spanning two adjacent genes in a tandem paralog cluster.

Authors:  Takeshi Tsuru; Ichizo Kobayashi
Journal:  Mol Biol Evol       Date:  2008-09-02       Impact factor: 16.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.